Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula

Long-term cognitive outcome study of children who participated in randomized trials of LCP-supplemented formula during infancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergy Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

5 day–12 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Retina Foundation of the Southwest

Dallas, Texas, 75231, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

children previously randomized in a clinical study consuming LCP-supplemented infant formula

Exclusion criteria

children who did not previously participate in a randomized clinical study consuming LCP-supplemented infant formula

Treatment and study plan

Primary outcomes

Prevalence of asthma and allergy related diagnosis in medical records during first 3 years of life.

Time frame: after first 3 years of life

Sponsors and collaborators

Lead sponsor

Mead Johnson Nutrition

Industry

Collaborators

National Institutes of Health (NIH)

Registry information

Important dates

First posted: Aug 25, 2008
Registry last updated: Aug 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed